Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CNS Pharmaceuticals Inc CNSP

Healthcare Biotechnology
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The Company's drug candidate, Berubicin, is the first anthracycline to appear to cross the blood-brain barrier. Berubicin is the subject of the Company's late-stage, fully-enrolled, global clinical trial for the treatment of glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. The Company's drug candidate, TPI 287, is an abeotaxane which stabilizes microtubules and inhibits cell division, causing apoptosis and cell death. TPI 287 has shown the potential to cross the blood-brain barrier and treat central nervous system (CNS) tumors.


NDAQ:CNSP - Post by User

CNS Pharmaceuticals Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(434)
•••
  • IseneschalX
Post by Iseneschalon Apr 14, 2023 12:12pm
89 Views
Post# 35395388

CNSP..... Not trying to fool anyone...especially anyone....

CNSP..... Not trying to fool anyone...especially anyone....who follows what I'm doing...... You all know me as a Day trader so I want to tell u all that I have sold my whole positon on CNSP... I made really good coin buy sticking to what I know and not getting "shakin out" when Mr. Maggot put the screws to us shareholders

I still feel this will go higher eventually....but I have a policy to sell the rips and buy the dips

I wish u all the best

 Cheers
Iseneschal
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities